secwatch.observer — SEC 8-K summary
======================================

Issuer:     OMEROS CORP (OMER)
CIK:        0001285819
Form:       8-K
Filed at:   2022-10-06T23:59:59+00:00
Accession:  0001558370-22-014884
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Omeros sells portion of OMIDRIA royalties for $125M; total capped payments of $188.4M through 2030
--------------------------------------------------------------------------------

- Received $125M upfront from DRI Healthcare for partial sale of OMIDRIA royalties.
- DRI gets capped payments: $1.67M in 2022, $13M in 2023, $20M in 2024, $25M/yr 2025-28, $26.25M 2029, $27.5M 2030.
- Total payments to DRI capped at $188.4M; Omeros retains royalties above annual caps.
- No recourse to Omeros assets beyond purchased receivables; no financial covenants.
- Agreement terminates Dec 31, 2030 or when DRI receives all payments due.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285819/000155837022014884/0001558370-22-014884-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285819/000155837022014884/omer-20220930x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-014884

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer